Kazakhstan vs Liberia: HIV-positive TB patients on ART (antiretroviral therapy)
Kazakhstan
87.0%
in 2024
Liberia
87.0%
in 2024
Kazakhstan rank
102nd
Liberia rank
102nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Kazakhstan
- Liberia
How they compare
Kazakhstan currently reports 87.0% against 87.0% in Liberia, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2008 it was Liberia ahead.
Kazakhstan ranks 102nd and Liberia ranks 102nd of 144 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 2 and Liberia in 1.
Head to head by decade
| Decade | Kazakhstan | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.4% | 44.0% | 34.6% | Liberia |
| 2010s | 71.5% | 39.7% | 31.8% | Kazakhstan |
| 2020s | 91.0% | 88.6% | 2.4% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Kazakhstan or Liberia?
- Kazakhstan, at 87.0% against 87.0% in Liberia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Kazakhstan and Liberia?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Liberia?
- 16 years are reported by both, from 2008 to 2024.
- How do Kazakhstan and Liberia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Kazakhstan ranks 102nd and Liberia ranks 102nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.